General unrestricted structure activity relationships based evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors

Der Pharma Chemica

Volumn 3, Issue 4, 2011, Pages 517-525

  Masand, Vijay H ^a   Mahajan, Devidas T ^a   Patil, Komalsing N ^a   Dawale, Nilesh E ^a   Hadda, Taibi Ben ^b   Alafeefy, Ahmed A ^c   Chinchkhede, Krushna D ^d  

^a Vidya Bharati College   (India)

^b FACULTÉ DES SCIENCES   (Morocco)

^c PRINCE SATTAM BIN ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d SANT GADGE BABA AMRAVATI UNIVERSITY   (India)

Author keywords

Anti influenza; Drug designing; Gusar; Quinoxaline derivatives

Indexed keywords

LIGAND; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 1A; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG STRUCTURE; INFLUENZA VIRUS; MOLECULAR MODEL; PREDICTION; PROCESS OPTIMIZATION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; RELIABILITY; STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS;

EID: 80052810798     PISSN: None     EISSN: 0975413X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. I. M. Lagoja, E. De Clercq, Med. Res. Rev. 2008, 28, 1-38
2. J. K. Taubenberger, D. M. Morens, Annu. Rev. Pathol. Mech. Dis., 2008, 3, 499-522.
3. L. You, E. J. Cho, J. Leavitt, L. C. Ma, G. T. Montelione, E. V. Anslyn, R. M. Krug, A. Ellington, J. D. Robertus, Bioorg. Med. Chem. Lett., 2011, 21: 3007-3011.
4. R. D. Jawarkar, V. H. Masand, K. N. Patil, D. T. Mahajan, M. H. Youssoufi, T. B. Hadda, S. L. Kumbhare, Der Pharma Chemica, 2010, 2(6): 302-310
5. R. D. Jawarkar, D. T. Mahajan, V. H. Masand, T. B. Hadda, G. H. Kurhade, Der Pharmacia Lettre, 2010, 2(6):350-357
6. A. M. Manikrao, P. N. Khatale, R. D. Jawarkar, J. V. Vyas, D. T. Mahajan, V. H. Masand, T. B. Hadda, J. Comput. Method. Mol. Design, 2011, 1 (2):9-13
7. V. H. Masand, K. N. Patil, D. T. Mahajan, R. D. Jawarkar, G. M. Nazerruddin, Der Pharma Chemica, 2010, 2(4): 298-308
8. V. H. Masand, K. N. Patil, G. M. Nazerruddin, R. D. Jawarkar, S. O Bajaj., Org. Chem.: An Ind. J., 2010, 6(1), 30-38
9. O. Deeb, B. Hemmateenejad, A. Jaber, R. Garduno-Juarez, R. Miri, Chemosphere, 2007, 67, 2122-2130.
10. Q. Shen, W.M. Shi, X.P. Yang, B.X. Ye, Eur. J. Med. Chem. Pharm. Sci., 2006, 28, 369-376.
11. X.J. Yao, A. Panaye, J.P. Doucet, H.F. Chen, R.S. Zhang, B.T. Fan, M.C. Liu, Z.D. Hu, Anal. Chim. Acta, 2005. 535, 259-273.
12. J.Z. Li, H.X. Liu, X.J. Yao, M.C. Liu, Z.D. Hu, B.T. Fan, Chemometr. Intell. Lab., 2007, 87, 139-146.
13. V. V. Poroikov, D. A. Filimonov, Y.V. Borodina, T. A. Gloriozova, V. B. Sitnikov, S.V. Sadovnikov, A. V. Sosnov, Pharma. Chem. J., 2004, 38(4), 188-190.
14. D. A. Filimonov, A.V. Zakharov, A.A. Lagunin, V.V. Poroikov, SAR and QSAR Environ. Res., 2009, 20 (7-8), 679-709
15. D. A. Filimonov, V. V. Poroikov, Y. V. Borodina, T. A. Gloriozova, J. Chem. Inf. Comput. Sci., 1999, 39, 666-670.
16. D. A. Filimonov D. A., D.V. Akimov, V. V. Poroikov, Pharm. Chem. J., 2004, 38 (1), 21-24.
17. www.acdlabs.com